News
Yale Researchers Explore Mindfulness-Based Treatments to Address Chronic Pain and Improve Health Outcomes in Individuals with Sickle Cell Disease
For individuals with Sickle Cell Disease (SCD), pain can be a pervasive aspect of everyday life, affecting both physical and mental health. An ongoing study in collaboration with the Yale Sickle Cell Program is set to examine the efficacy of mindfulness-based treatments (MBT) to address pain and improve quality of life for SCD patients. Led by Zachary Harvanek, MD, PhD, John Roberts, MD, Ariadna Forray, MD, and Michael Crowley, PhD, “Neural Correlates of Pain, Resiliency, and Mindfulness in Patients with Sickle Cell Disease” will explore neural markers of chronic pain in patients with SCD and assess whether MBT can improve both chronic pain and SCD in this population.